Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Coformulation of Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab (MK-3475) Monotherapy for Programmed Cell Death 1 Ligand 1 (PD-L1) Positive Metastatic Non-Small Cell Lung Cancer (MK-7684A-
ClinicalTrials.gov study NCT04738487. IPD Sharing: YES. Countries: 23. Publications: 0.
An RCT of a Telemedicine Intervention for Hypokinetic Dysarthria in PD
ClinicalTrials.gov study NCT04617496. IPD Sharing: NO. Countries: 1. Publications: 0.
Short-course Radiotherapy Combined With Chemotherapy and Pd-1 Inhibitor for Locally Advanced Colon Cancer(TORCH-C)
ClinicalTrials.gov study NCT05732493. IPD Sharing: NO. Countries: 0. Publications: 1.
Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
ClinicalTrials.gov study NCT04767906. IPD Sharing: YES. Countries: 1. Publications: 0.
PK PD of the Enantiomers of Tramadol and O-desmethyltramadol in Elderly and Young Subjects
ClinicalTrials.gov study NCT02329561. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Open-label Study to Evaluate the Safety, PK, and PD of MEK Inhibitor GSK1120212 in Subjects With Relapsed or Refractory Leukemias
ClinicalTrials.gov study NCT00920140. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Pro
ClinicalTrials.gov study NCT03321630. IPD Sharing: NO. Countries: 1. Publications: 0.
PK and PD Study of IDN-6556 in Subjects With Hepatic Impairment and Matched Healthy Volunteers
ClinicalTrials.gov study NCT02121860. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
ClinicalTrials.gov study NCT05740995. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 1 Trial of TST of PD 0332991 Followed by Cytarabine and Mitoxantrone for Adults With Relapsed and Refractory Acute Leukemias and High-Risk Myelodysplasia
ClinicalTrials.gov study NCT01701375. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stimulation Parameters and Non-motor Symptoms in PD Treated With DBS
ClinicalTrials.gov study NCT03800108. IPD Sharing: NO. Countries: 1. Publications: 0.
Anti-PD-1 Antibody With HD IL-2 in Metastatic Melanoma
ClinicalTrials.gov study NCT03476174. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients with Hyperuricemia
ClinicalTrials.gov study NCT06056570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single Dose PD & PK Study With Two Formulations of Abediterol in Patients With Asthma
ClinicalTrials.gov study NCT02777827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SBRT Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT03050554. IPD Sharing: NO. Countries: 1. Publications: 0.
AGEN1884, an Anti-CTLA-4 Human Monoclonal Antibody in Participants With Advanced or Refractory Cancer and Who Have Progressed With PD-1/PD-L1 Inhibitor as Their Most Recent Therapy
ClinicalTrials.gov study NCT02694822. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 Alone or With Dendritic Cell/Renal Cell Carcinoma Fusion Cell Vaccine
ClinicalTrials.gov study NCT01441765. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atezolizumab and Tiragolumab in Patients With NSCLC or Advanced Solid Tumors Having Had Prior Treatment With a PD-1 Inhibitor
ClinicalTrials.gov study NCT03977467. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Electroacupuncture Combined With PD-1 Inhibitor for ECOG2 Advanced NSCLC
ClinicalTrials.gov study NCT07239661. IPD Sharing: NO. Countries: 1. Publications: 0.
Camrelizumab Combined With Apatinib Mesylate or Camrelizumab Alone for First-line Treatment in Subjects With Programmed Death Ligand 1 (PD-L1) Positive Relapsed or Advanced Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04203485. IPD Sharing: Not stated. Countries: 0. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.